Keywords: elan, migraine, drug, nears, approval, frovatriptan, developed

Elan's migraine drug nears US approval

Article | 04 May 2000

Print This

Frovatriptan, the migraine drug developed by Vanguard Medica of the UKand licensed to Ireland's Elan, has moved a step closer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in